Sopharma Trading AD Sustainability Profile
Sopharma Trading AD, a leading player in the pharmaceutical distribution sector, is headquartered in Bulgaria (BG) and operates extensively across Southeast Europe. Founded in 1998, the company has established itself as a trusted partner in the healthcare industry, focusing on the distribution of pharmaceuticals, medical devices, and healthcare products. With a commitment to quality and innovation, Sopharma Trading AD offers a diverse portfolio of core services, including logistics, marketing, and sales support for healthcare providers. The company is recognised for its robust supply chain management and customer-centric approach, ensuring timely delivery of essential medical products. Sopharma Trading AD has achieved significant milestones, positioning itself as a market leader in Bulgaria and the surrounding regions. Its dedication to excellence and strategic partnerships has earned the company a reputation for reliability and efficiency in the pharmaceutical landscape.
DitchCarbon Score
How does Sopharma Trading AD's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sopharma Trading AD's score of 16 is lower than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sopharma Trading AD's reported carbon emissions
Sopharma Trading AD, headquartered in Bulgaria (BG), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of Sopharma AD, which may influence its climate commitments and reporting practices. While there are no documented reduction targets or climate pledges from Sopharma Trading AD, it is important to note that emissions data may be inherited from its parent company, Sopharma AD. This relationship could potentially provide insights into broader corporate sustainability initiatives and climate strategies. As of now, Sopharma Trading AD has not established specific science-based targets (SBTi) or other reduction initiatives. The lack of available data suggests that the company may still be in the early stages of developing its climate commitments or reporting frameworks. In summary, Sopharma Trading AD's current climate impact remains unclear due to the absence of emissions data and defined reduction targets, but its affiliation with Sopharma AD may play a role in shaping its future sustainability efforts.
How Carbon Intensive is Sopharma Trading AD's Industry?
How Carbon Intensive is Sopharma Trading AD's Location?
Sopharma Trading AD's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Sopharma Trading AD has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
